MKTX News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

MK

Mkt Cap

$5.79B

Volume

444.55K

Next Earnings

November 6th

Loading chart

MK

MKTXMarketAxess Holdings Inc.

MKTX

Pay with—

Available Balance0.00

MK

Mkt Cap

$5.79B

Volume

444.55K

Next Earnings

November 6th

Chart Financials Earnings News About Dividends Insider Filings

MKTX Expands Fixed Income Data Reach Through Arcesium IntegrationMarketAxess Holdings Inc. (MKTX) has expanded its partnership with Arcesium by integrating its CP+ and TraX datasets into Arcesium's platforms, enabling institutional clients to access pricing, liquidity, and transaction data within their existing workflows. Building on the existing Repo Match service that handles over $700 billion in daily volume, this integration aims to strengthen MKTX's data and analytics business and create new monetization opportunities. However, MKTX shares have underperformed year-to-date, falling 9.3% against the industry's 0.9% growth.Zacks Investment Research · Oct 8, 2026

BGC or MKTX: Which Is the Better Value Stock Right Now?BGC Group and MarketAxess are compared as potential value stock investments in the Financial - Investment Bank sector. BGC Group emerges as the superior value option with a Zacks Rank of #2 (Buy) versus MarketAxess's #3 (Hold), supported by a lower forward P/E ratio of 8.56 compared to 20.36, and a better Value grade of B versus D.Zacks Investment Research · Oct 6, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and ensure fair value for shareholders. The investigations involve Personalis (acquired by Tempus AI for $16.25/share), Werewolf Therapeutics (acquired by Ambros Therapeutics), Beazer Homes (acquired by Dream Finders Homes for $33.50/share), and MarketAxess Holdings (acquired by Intercontinental Exchange for $167/share).GlobeNewswire Inc. · Sep 3, 2026

Here's Why Investors Should Stay Neutral on MarketAxess Stock for NowMarketAxess (MKTX) is diversifying beyond U.S. credit with international expansion and new trading protocols, with non-U.S. credit revenues rising 9%. However, U.S. credit revenues declined 9%, and the stock carries an elevated forward P/E of 19.08X above industry average. The company maintains strong financials and consistent earnings beats, but faces risks from trading volume sensitivity and investment costs, warranting a neutral stance.Zacks Investment Research · Sep 3, 2026

MKTX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of MarketAxess to Intercontinental ExchangeLaw firm Wohl & Fruchter is investigating whether the proposed sale of MarketAxess to Intercontinental Exchange at $167.00 per share is fair to shareholders, given the stock's 52-week high of $200.90 and a recent UBS price target of $200.00. Shareholders have expressed concerns that the deal undervalues the company.GlobeNewswire Inc. · Aug 6, 2026

Halper Sadeh LLC is Investigating Whether FBRX, LXFR, SMTI, MKTX are Obtaining Fair Deals for their ShareholdersHalper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether insiders are receiving substantial benefits unavailable to ordinary shareholders and whether transaction terms limit competing offers. The investigations cover Forte Biosciences' sale to argenx, Luxfer Holdings' sale to Wynnchurch Capital affiliates, Sanara MedTech's sale to MiMedx Group, and MarketAxess Holdings' sale to Intercontinental Exchange.GlobeNewswire Inc. · Aug 5, 2026

Halper Sadeh LLC is Investigating Whether MKTX, SMTI, LNTH are Obtaining Fair Deals for their ShareholdersHalper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers.GlobeNewswire Inc. · Aug 4, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether the boards of MarketAxess Holdings, CBIZ, Sanara MedTech, and TriCo Bancshares breached fiduciary duties by failing to conduct fair processes and potentially underpaying shareholders. The firm is seeking shareholders to discuss potential class action lawsuits.GlobeNewswire Inc. · Jul 30, 2026

MarketAxess (MKTX) Q2 Revenue Up 11%MarketAxess reported record Q2 2025 revenue of $219.5 million, growing 11% year-over-year, with Non-GAAP EPS of $2.00. The company saw significant trading volume increases across various bond market segments, while experiencing margin pressure from evolving trading protocols.The Motley Fool · Aug 6, 2025

Capitalize on Volatility: 3 Finance Stocks Thriving in 2025The article highlights three finance stocks positioned to benefit from market volatility in 2025, focusing on derivatives trading, investment banking, and electronic bond trading platforms.Investing.com · Jul 2, 2025

to start trading

MK

MKTXMarketAxess Holdings Inc.

MKTX

Pay with—

Available Balance0.00

Your PositionYou don't own any MKTX yet.

Related Tickers

Earnings

Dividends

Last · Aug 19Quarterly

Amount$0.78

Yield1.88%

Annual$3.10